Literature DB >> 18849700

New technologies in radiation therapy: ensuring patient safety, radiation safety and regulatory issues in radiation oncology.

Howard I Amols1.   

Abstract

New technologies such as intensity modulated and image guided radiation therapy, computer controlled linear accelerators, record and verify systems, electronic charts, and digital imaging have revolutionized radiation therapy over the past 10-15 y. Quality assurance (QA) as historically practiced and as recommended in reports such as American Association of Physicists in Medicine Task Groups 40 and 53 needs to be updated to address the increasing complexity and computerization of radiotherapy equipment, and the increased quantity of data defining a treatment plan and treatment delivery. While new technology has reduced the probability of many types of medical events, seeing new types of errors caused by improper use of new technology, communication failures between computers, corrupted or erroneous computer data files, and "software bugs" are now being seen. The increased use of computed tomography, magnetic resonance, and positron emission tomography imaging has become routine for many types of radiotherapy treatment planning, and QA for imaging modalities is beyond the expertise of most radiotherapy physicists. Errors in radiotherapy rarely result solely from hardware failures. More commonly they are a combination of computer and human errors. The increased use of radiosurgery, hypofractionation, more complex intensity modulated treatment plans, image guided radiation therapy, and increasing financial pressures to treat more patients in less time will continue to fuel this reliance on high technology and complex computer software. Clinical practitioners and regulatory agencies are beginning to realize that QA for new technologies is a major challenge and poses dangers different in nature than what are historically familiar.

Entities:  

Mesh:

Year:  2008        PMID: 18849700     DOI: 10.1097/01.HP.0000326334.64242.46

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  7 in total

1.  Investment in radiotherapy infrastructure positively affected the economic status of an oncology hospital.

Authors:  Mirella Smigielska; Piotr Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2012-05-18

2.  Pilot study of meaningful use of electronic health records in radiation oncology.

Authors:  Xinglei Shen; Adam P Dicker; Laura Doyle; Timothy N Showalter; Amy S Harrison; Susan I DesHarnais
Journal:  J Oncol Pract       Date:  2012-03-20       Impact factor: 3.840

Review 3.  Radiotherapy: Basic Concepts and Recent Advances.

Authors:  S R Mehta; V Suhag; M Semwal; N Sharma
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  An Investigation of Radiation Treatment Learning Opportunities in Relation to the Radiation Oncology Electronic Medical Record: A Single Institution Experience.

Authors:  Y Jessica Huang; Vikren Sarkar; Adam Paxton; Hui Zhao; Frances Fan-Chi Su; Ryan Price; Bill J Salter
Journal:  Adv Radiat Oncol       Date:  2021-09-29

Review 5.  Quality and Safety With Technological Advancements in Radiotherapy: An Overview and Journey Narrative From a Low- and Middle-Income Country Institution.

Authors:  Jifmi Jose Manjali; Rahul Krishnatry; Jatinder R Palta; J P Agarwal
Journal:  JCO Glob Oncol       Date:  2022-08

6.  Common Error Pathways in CyberKnife™ Radiation Therapy.

Authors:  Brandon T Mullins; Lukasz Mazur; Michael Dance; Ross McGurk; Eric Schreiber; Lawrence B Marks; Colette J Shen; Michael V Lawrence; Bhishamjit S Chera
Journal:  Front Oncol       Date:  2020-07-08       Impact factor: 6.244

Review 7.  MicroRNAs in Cancer Treatment-Induced Cardiotoxicity.

Authors:  Laura Pellegrini; Sara Sileno; Marco D'Agostino; Eleonora Foglio; Maria Cristina Florio; Vincenzo Guzzanti; Matteo Antonio Russo; Federica Limana; Alessandra Magenta
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.